Ocup stock forecast.
The forecasts range from a low of $16.00 to a high of $20.00. The average price target represents an increase of 516.44% from the last closing price of $2.92. …
Ocuphire Pharma, Inc. ( NASDAQ:OCUP) investors will be delighted, with the company turning in some strong numbers with its latest results. Performance was better than the analysts expected, with revenues of US$40m coming in42% ahead of expectations, and statutory earnings per share (EPS) of US$0.87 exceeding forecasts by 18%.Based on the Ocuphire Pharma Inc stock forecast from 2 analysts, the average analyst target price for Ocuphire Pharma Inc is USD 19.00 over the next 12 months. Ocuphire Pharma Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Ocuphire Pharma Inc is Slightly Bullish , which is based on 6 positive ... The latest Ocuphire Pharma stock prices, stock quotes, news, and OCUP history to help you invest and trade smarter. ... The 8 analysts offering price forecasts for Ocuphire Pharma have a median ...Get the latest Ocuphire Pharma Inc (OCUP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The average Rigetti Computing stock price prediction forecasts a potential upside of 185.71% from the current RGTI share price of $1.05. What is RGTI's forecast return on assets (ROA) for 2023-2024? (NASDAQ: RGTI) forecast ROA is -25.53%, which is lower than the forecast US Computer Hardware industry average of 11.16%.
Find real-time OCUL - Ocular Therapeutix Inc stock quotes, company profile, news and forecasts from CNN Business.Analyst forecast price: $23.2. 52-week high/low: $5.5 / $1.78. On the global stage, Ocuphire Pharma, Inc. commands attention, with its shares actively traded under the ticker OCUP. A notable entity in the "Healthcare" sector, it showcases a blend of innovation and market resilience.
OCUP : Ocuphire Pharma stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical AnalysisFind the latest {companyName} COUP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. report type.
Ocuphire Pharma, Inc. Common Stock (OCUP) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Performance was better than the analysts expected, with revenues of US$40m coming in42% ahead of expectations, and statutory earnings per share (EPS) of US$0.87 exceeding forecasts by 18%.The average Ocuphire Pharma stock price prediction forecasts a potential upside of 585.19% from the current OCUP share price of $2.70. What is OCUP's forecast return …The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.61 by $0.19. The business earned $33.64 million during the quarter, compared to analyst estimates of $35.10 million. Crawford United had a net margin of 9.20% and a trailing twelve-month return on equity of 26.88%.
About the Rexahn Pharmaceuticals, Inc. stock forecast. As of 2023 November 25, Saturday current price of OCUP stock is 2.820$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).
About the Rexahn Pharmaceuticals, Inc. stock forecast. As of 2023 November 25, Saturday current price of OCUP stock is 2.820$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).
Their OCUP share price targets range from $17.00 to $20.00. On average, they expect the company's share price to reach $18.50 in the next twelve months. This suggests a possible upside of 518.7% from the stock's current price. View analysts price targets for OCUP or view top-rated stocks among Wall Street analysts.Ocuphire Pharma Stock Chart and Share Price Forecast, Short-Term "OCUP" Stock Prediction for Next Days and Weeks Walletinvestor.com Ocuphire Pharma Inc (OCUP) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Ocuphire Pharma (OCUP) has an AI Score of -/10 ({{message_score}}) because its overall probability of beating the market (S&P 500) in the next 3 months …Dec 4, 2023 · As of last trade, Ocuphire Pharma Inc (OCUP:NAQ) traded at 2.87, 15.73% above the 52 week low of 2.48 set on Dec 27, 2022. Data delayed at least 15 minutes, as of Dec 04 2023 18:10 GMT. Latest Ocuphire Pharma Inc (OCUP:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. View %COMPANY_NAME% COUP investment & stock information. Get the latest %COMPANY_NAME% COUP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.OCUP Overview Stock Screener Earnings Calendar Sectors Nasdaq | OCUP U.S.: Nasdaq Ocuphire Pharma Inc. Watch list NEW Set a price target alert After Hours Last Updated: …
The maker of business spending management software forecast revenue in a range of $202 million to $205 million, slightly below estimates of $205.3 million. San Mateo, Calif.-based Coupa reported ...3,076. Rob Bernshteyn. https://www.coupa.com. Coupa Software Incorporated provides cloud-based business spend management platform that connects its customers with suppliers worldwide. The company provides visibility into and control over how companies spend money, optimize supply chains, and manage liquidity, as well as …NSD:OCUP Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesUnlock tomorrow's (OCUP) stock trends with our detailed analysis. Get insights on Ocuphire Pharma, Inc.'s performance, backed by data-driven predictions for informed investment.Target values for the price of one Ocuphire Pharma share for Dec 2023. The weighted average target price per Ocuphire Pharma share in Dec 2023 is: 3.33. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 19.524% volatility is expected. Pessimistic target level: 2.81.The average Ocuphire Pharma stock price prediction forecasts a potential upside of 585.19% from the current OCUP share price of $2.70. What is OCUP's forecast return …The average Rigetti Computing stock price prediction forecasts a potential upside of 185.71% from the current RGTI share price of $1.05. What is RGTI's forecast return on assets (ROA) for 2023-2024? (NASDAQ: RGTI) forecast ROA is -25.53%, which is lower than the forecast US Computer Hardware industry average of 11.16%.
If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...
Average Age. Experienced Board: OCUP's board of directors are considered experienced (3 years average tenure). View Ownership. Learn about Ocuphire Pharma, Inc. (OCUP) stock's management team. Comprehensive performance, salary and tenure analysis for the CEO, board and leadership team.Overview Stock Screener Earnings Calendar Sectors Nasdaq | OCUP U.S.: Nasdaq Ocuphire Pharma Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 8, 2023 6:14 p.m. EST...beststocks.comUBS O'Connor LLC. 2.13. Barclays Bank Plc. 2.10. The latest Coupa Software stock prices, stock quotes, news, and COUP history to help you invest and trade smarter. Ocuphire Pharma, Inc. (OCUP) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 2.9900 -0.0600 (-1.97%) At close: 04:00PM EST 3.2000 +0.21 (+7.02%) After hours: 06:30PM EST 1dOcuphire Pharma, Inc. (OCUP) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 2.9900 -0.0600 (-1.97%) At close: 04:00PM EST 3.2000 +0.21 (+7.02%) After hours: 06:30PM EST 1d
Ocuphire Pharma stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Ocuphire Pharma cost in 2023 – 2027?
Stock Price Forecast The 5 analysts offering 12-month price forecasts for Ocuphire Pharma Inc have a median target of 20.00, with a high estimate of 24.00 and a low estimate of 16.00.
Ocuphire Pharma (OCUP) (Delayed Data from NSDQ) $2.81 USD -0.04 (-1.40%) Updated Nov 22, 2023 04:00 PM ET After-Market: $2.80 -0.01 (-0.36%) 7:58 PM …In a report released today, Matthew Caufield from H.C. Wainwright reiterated a Buy rating on Ocuphire Pharma (OCUP – Research Report), with a price target of $20.00.The company’s shares closed ...Coupa Software (COUP) stock consensus forecasts for 2023. Last update: 09/12/2023, 12:15 PM. Brief information about Coupa Software Inc. ...Find the latest Ocuphire Pharma, Inc. (OCUP) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Ocuphire Pharma. Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer.Past criteria checks 4/6. Ocuphire Pharma has been growing earnings at an average annual rate of 22.1%, while the Pharmaceuticals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 99% per year. Ocuphire Pharma's return on equity is 57.2%, and it has net margins of 50.3%.The average price target is $5.17 with a high forecast of $9.00 and a low forecast of $3.00. The average price target represents a 102.75% change from the last price of $2.55 .Nov 30, 2023 · According to 2 stock analysts, the average 12-month stock price forecast for OCUP stock stock is $18.5, which predicts an increase of 518.73%. The lowest target is $17 and the highest is $20. On average, analysts rate OCUP stock stock as a strong buy.
Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.GGB Earnings Forecast. Next quarter’s earnings estimate for GGB is $0.17 with a range of $0.14 to $0.20. The previous quarter’s EPS was $0.19. GGB beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.34% of the time in the same period.Asset Growth. 142.83%. Trailing 12-Months. The Ocuphire Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst …Instagram:https://instagram. best stock trading toolssp 400 indexotcmkts ptraqhow do you test to see if gold is real Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast. dental and vision insurance south carolinaspirit vision insurance The Ocuphire Pharma, Inc. stock price fell by -1.24% on the last day (Monday, 27th Nov 2023) from $2.83 to $2.79. During the last trading day the stock fluctuated 11.74% from a day low at $2.63 to a day high of $2.94. The price has fallen in 6 of the last 10 days and is down by -1.41% for this period. Volume has increased on the last day by 277 ... clnn stock forecast Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...3.68%. $17.12. Check if COUP Stock has a Buy or Sell Evaluation. COUP Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Coupa Software Incorporated News.Nov 22, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Ocuphire Pharma stock is Buy based on the current 2 buy ratings for OCUP. The average twelve-month price prediction for Ocuphire Pharma is $18.50 with a high price target of $20.00 and a low price target of $17.00. Learn more on OCUP's analyst rating history.